Starbucks Corp vs Teladoc Health Inc — how do they compare? Starbucks Corp trades at $90.87 (market cap $106.26B), while Teladoc Health Inc trades at $5.79 (market cap $1.01B). The key difference: Starbucks Corp is far larger — about 105.2× Teladoc Health Inc's market cap, and Starbucks Corp pays a 2.7% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Starbucks Corp for 190 Days and Teladoc Health Inc for 39 Days on average.
| SBUX | TDOC | |
|---|---|---|
Market Cap | $106.26B | $1.01B |
Volume | 30,248,434 | 4,668,477 |
Sector | Consumer Cyclical | Health |
52-Week High | $108.55 | $9.72 |
52-Week Low | $78.46 | $4.47 |
Typical Hold Time | 190 Days | 39 Days |
Enterprise Value | $125.08B | $1.27B |
Dividend Yield | 2.7% | — |
Signals from Pluang's Aura AI — not financial advice
Starbucks (SBUX) trades at $91.66, down 2.05% amid a bearish technical outlook with support at $89 and resistance at $92. The company reported mixed quarterly results with Q2 2026 EPS beating expectations at $0.85 vs. $0.66, but Q4 2025 missed at $0.56. Recent news highlights store closures and restructuring charges of approximately $300 million as part of a strategic turnaround. Revenue growth remains modest at $37.18B for 2025, with net income margin at 5.17%.
The stock presents a cautious opportunity with analyst consensus price target of $115.50 implying 26% upside, though high P/E of 53.88 raises valuation concerns. Key risks include execution of store optimization, labor relations, and geopolitical tensions in China. Institutional sentiment is divided with 47% buy ratings, but technical indicators signal near-term pressure.
Teladoc Health (TDOC) trades at $5.67, showing modest daily gains but remains near multi-year lows with a bearish technical outlook. The company maintains strong revenue around $2.5B annually but continues to report net losses, with a -7.13% net margin in 2026. Recent management changes include the appointment of a new CFO, while analyst sentiment remains cautious despite a consensus price target of $8.83 representing 56% upside potential.
TDOC presents a high-risk opportunity with significant upside potential if the company can achieve profitability turnaround. The stock trades at discounted valuations (P/S 0.4x, P/B 0.77x) but faces execution risks from ongoing losses, BetterHelp segment challenges, and potential legal investigations. Free cash flow generation and integrated care growth provide stabilization, though sustained profitability remains the key catalyst needed for sustained recovery.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →